Optimal perioperative nutrition therapy for patients undergoing pancreaticoduodenectomy: A systematic review with a component network meta-analysis

  • Shang Yu Wang
  • , Yu Liang Hung
  • , Chih Chieh Hsu
  • , Chia Hsiang Hu
  • , Ruo Yi Huang
  • , Chang Mu Sung
  • , Yan Rong Li
  • , Hao Wei Kou
  • , Ming Yang Chen
  • , Shih Chun Chang
  • , Chao Wei Lee
  • , Chun Yi Tsai
  • , Keng Hao Liu
  • , Jun Te Hsu
  • , Chun Nan Yeh*
  • , Ta Sen Yeh
  • , Tsann Long Hwang
  • , Yi Yin Jan
  • , Miin Fu Chen
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations

Abstract

Numerous strategies for perioperative nutrition therapy for patients undergoing pancreati-coduodenectomy (PD) have been proposed. This systematic review aimed to summarize the current relevant published randomized controlled trials (RCTs) evaluating different nutritional interventions via a traditional network meta-analysis (NMA) and component network meta-analysis (cNMA). EMBASE, MEDLINE, the Cochrane Library, and ClinicalTrials.gov were searched to identify the RCTs. The evaluated nutritional interventions comprised standard postoperative enteral nutrition by feeding tube (Postop-SEN), preoperative enteral feeding (Preop-EN), postoperative immunonutrients (Postop-IM), preoperative oral immunonutrient supplement (Preop-IM), and postoperative total parenteral nutrition (TPN). The primary outcomes were general, infectious, and noninfectious complications; postoperative pancreatic fistula (POPF); and delayed gastric emptying (DGE). The secondary outcomes were mortality and length of hospital stay (LOS). The NMA and cNMA were conducted with a frequentist approach. The results are presented as odds ratios (ORs) and 95% confidence intervals (CIs). Two primary outcomes, infectious complications and POPF, were positively influenced by nutritional interventions. Preop-EN plus Postop-SEN (OR 0.11; 95% CI 0.02~0.72), Preop-IM (OR 0.22; 95% CI 0.08~0.62), and Preop-IM plus Postop-IM (OR 0.11; 95% CI 0.03~0.37) were all demonstrated to be associated with a decrease in infectious complications. Postop-TPN (OR 0.37; 95% CI 0.19~0.71) and Preop-IM plus Postop-IM (OR 0.21; 95% CI 0.06~0.77) were clinically beneficial for the prevention of POPF. While enteral feeding and TPN may decrease infectious complications and POPF, respectively, Preop-IM plus Postop-IM may provide the best clinical benefit for patients undergoing PD, as this approach decreases the incidence of both the aforementioned adverse effects.

Original languageEnglish
Article number4049
JournalNutrients
Volume13
Issue number11
DOIs
StatePublished - 11 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

  • Immunonutrition
  • Network meta-analysis
  • Nutrition therapy
  • Pancreaticoduodenectomy
  • Postoperative pancreatic fistula

Fingerprint

Dive into the research topics of 'Optimal perioperative nutrition therapy for patients undergoing pancreaticoduodenectomy: A systematic review with a component network meta-analysis'. Together they form a unique fingerprint.

Cite this